Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Microstrategy Inc BYD Co Ltd Daily Open
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Market Outlook World Markets SAP AG
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Science Novo Nordisk A/S LILLY DRN
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags LVMH Moet Hennessy Louis Vuitton SE Breaking News: Markets Novo Nordisk A/S
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags AstraZeneca PLC Business Health & Science
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Business Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Health care industry Social issues Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business Economic events Economy
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Europe News Breaking News: Markets Pharmaceuticals
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Health & Science Business Health care industry
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Structure Therapeutics Inc LILLY DRN GE HealthCare Technologies Inc
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Health & Science Business Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Novo Nordisk A/S Investment Strategy Stock Picks
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Science Hims & Hers Health Inc Novo Nordisk A/S
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Europe Economy U/S/ Economy US Economy
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Pfizer Inc Pharmaceuticals Companies
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Health & Science Mobile Breaking News: Technology
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Earnings Novo Nordisk A/S Health care industry
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Biotech and Pharmaceuticals LILLY DRN Breaking News: Europe
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Health & Science Social issues Health care industry
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Investment Strategy Stock Picks stocks
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags US: News Breaking News: Business Biotechnology
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Breaking News: Business Retail industry Compagnie Financiere Richemont SA
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.